Compare Abbott Laboratories (ABT) vs Brunswick Corporation (BC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Brunswick Corporation — how do they compare? Abbott Laboratories trades at $95.44 (market cap $166.94B), while Brunswick Corporation trades at $75.55 (market cap $5.02B). The key difference: Abbott Laboratories is far larger — about 33.3× Brunswick Corporation's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | BC | |
|---|---|---|
Market Cap | $166.94B | $5.02B |
Sector | Health | Consumer Cyclical |
52-Week High | $136.62 | $89.22 |
52-Week Low | $82.57 | $56.64 |
Enterprise Value | $193.69B | $7.19B |
Dividend Yield | 2.63% | 2.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
BC trades at $77.33, down 2.23% today, with a bearish technical signal and mixed earnings history. Revenue declined to $5.36B in 2025 with a net loss of $137.30M, though recent quarters beat expectations. The company maintains strong analyst support with a $86.40 consensus target and announced a $0.44 dividend for H1-26. Cash flow improved to a near-neutral -$11M in 2025 from deeper losses in prior years.
Outlook is cautious due to profitability challenges and high P/E of 73.92, but expansion news like Freedom Boat Club's 450th location offers growth potential. Risks include sustained negative margins and debt levels, while institutional buy ratings suggest confidence in a turnaround if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Brunswick Corporation
Brunswick Corp is the leader in several recreational sectors. The firm is the leading boat manufacturer, and its brands include Mercury and Mariner outboard engines
Read more on BC →
